Editorial Panel


Dr. Niyaz Ahmad Naikoo

Assistant Professor Dept. Of Biotechnology J&K Higher Education Department Cluster University J&K, India
I, Niyaz Ahmad Naikoo obtained masters in Biotechnology from University of Kashmir. Worked as Lecturer/Assistant Professor in Biotechnology at S.P College Srinagar and Boys Degree College Anantanag Jammu & Kashmir, India and then pursued doctorate in Immunology & Molecular Medicine at SKIMS India in 2012.
In 2012, i moved to Division of Biotechnology at SKUAST-K, J&K India, where i began work on the Hand Made Cloning of Ruminants and differential gene expression using q-PCR till 2016. I have more than six years of Research and teaching experience and over 22 national and international publications. Currently I am delivering duties as Assistant professor in the division of Biotechnology in Cluster University, Govt. College for Women M.A Road Srinagar J&K India and i am editorial Board member of journals like Insights in Surgery, Current Research in Molecular Medicine and reviewer for journals of Gene, Tumori, tumor Biology and Journal of Gene Medicine.
His research interest is to understand the molecular mechanisms of cancer initiation and progression and developing novel strategies for diagnosis and treatment. My work focuses on studying several cancer-related signaling pathways and biological processes. These include cross talks between receptor tyrosine kinase (RTK) pathways, tumor growth and metastasis development as well as resistance to existing treatments, particularly in lung cancer. I have thorough experience in in-vitro/in-vivo experiments, microscopy, microbiology, biological data analysis, interpretation and hypothesis generation mice handling, lymphocyte proliferation assays, macrophage collection test, ELISA, delayed type hypersensitive test in mice, chromatography techniques like molecular sieve chromatography, electrophoretic techniques like PAGE with more than four years of teaching/research experience and published more than 18 articles as journals, conferences and other articles. Experience in Nucleic acid (DNA and RNA) purification and handling expertise, Extensive experience with PCR and quantitative real-time PCR, Experience with primer and probe design. Hands on skills in PCR, RT-PCR. Genotyping using qPCR, Experience in SNP, SSR, ISSR, and RAPD genotyping techniques and data analysis. Familiar with sequencing technologies and molecular based disease diagnostics, proficient in data interpretation. Gene cloning ( Transformation, Transfection), Establishment and maintenance of mammalian cell lines (Primary cell culture, Fibroblast Cell culture) for transfection, Differential gene expression through qPCR
Proficiency in Microsoft office, SPSS, Graphpad prism, Chromas, Clustal X,Primer designing, Familiar with sequence alignment software etc.
1. Single nucleotide polymorphisms, haplotype association and tumour expression ofthe vascular endothelial growth factor (VEGF) gene with lung carcinoma.
Niyaz A Naykoo, Dil-Afroze, Roohi Rasool, Sonaullah Shah, A.G Ahangar, Imtiyaz A Bhat, Iqbal Qasim, Mushtaq A Siddiqi, Zafar A Shah
Gene 608 (2017) 95–102
2. Vascular endothelial growth factorA gene (VEGFA) polymorphisms and expression of VEGFA gene in lung cancer patients of Kashmir Valley (India).

Niyaz A Naik, Imtiyaz A Bhat, Dil Afroze, Roohi Rasool, Hyder Mir,Syed Irtiza Andrabi, Sonaullah Shah, Mushtaq A Siddiqi, Zafar A Shah
Tumor Biology (2012) 33:833–839
3. CTTTA Deletion/Insertion polymorphism in 3'-UTR of LEPR gene in type 2 diabetes subjects belonging to Kashmiri population.

Iqra Hameed, Shariq R Masoodi, Dil Afroze, Riyaz A Bhat, Niyaz A Naykoo, Shahnaz A Mir, Idrees Mubarik, Bashir A Ganai. Hameed I
Journal of Diabetes & Metabolic Disorders (2014) 13:124.
4. Contribution of TGFb1 Codon 10 Polymorphism to High Myopia in an Ethnic Kashmiri Population from India.

Shabhat Rasool, Ishfaq Ahmed, Rubiya Dar, Sheikh Gazalla Ayub,Sabia Rashid,Tariq Jan, Tahir Ahmed, Niyaz A Naikoo, Khurshid I. Andrabi
Biochem Genetics (2013) 51(3-4):323-33
5. Role of Skin Prick Test in Allergic Disorders: A Prospective Study in Kashmiri Population in Light of Review.

Roohi Rasool, Irfan Ali Shera, Saniya Nissar, Zaffar A Shah, Niyaz Nayak, Mushtaq A Siddiqi, Aga Syed Sameer
Indian Journal of Dermatology (2013) 58(1)

6. Open pulled straw (OPS) vitrification and slow freezing of sheep IVF embryos using different cryoprotectants.

M H Bhat, V Sharma, F A Khan, Niyaz A Naykoo, S H Yaqoob, Gabor Vajita, Hilal Ahmad, M R Fazili, N A Ganai and R A Shah
Reproduction Fertility and Development (2014)
7. Trp Homozygotes at Codon 64 of ADRB3 Gene Are Protected Against the Risk of Type 2 Diabetes in the Kashmiri Population

Iqra Hameed, Shariq R. Masoodi, Niyaz A Naykoo, Riyaz A. Bhat, Bashir A. Ganai
Genetic Testing and Molecular Biomarkers (2013) 17 (10) 775–779.
8. TGIF1 is a Potential Candidate Gene for High Myopia in Ethnic Kashmiri Population.

Ishfaq Ahmed, Shabhat Rasool, Tariq Jan, Tariq Qureshi, Niyaz A Naykoo and Khurshid I. Andrabi
Current Eye Research (2013) 39(3):282-90
9. Lack of Association of a Common Polymorphism in the 3' -UTR of Interleukin 8 with Non Small Cell Lung Cancer in Kashmir.

Bhat IA, Pandith AA, Bhat BA, Naykoo N A, Qasim I, Rasool R, Aziz SA, Shah ZA
Asian Pacific Journal of Cancer Prevention (2013) 14 (7), 4403-4408
10. Molecular characterization of RNA binding motif protein 3 (RBM3) gene from Pashmina goat.

Ruby Zargar, Uneeb Urwat, Firdose Malik, Riaz A. Shah, M.H. Bhat, Niyaz A Naykoo, Firdous Khan, H.M. Khan, Syed Mudasir Ahmed, Ramesh Kumar Vijh, Nazir A. Ganai.
Research in Veterinary Science (2015) 98, 51–58.
11. Comparison of Slow Freezing and Vitrification on Ovine Immature Oocytes.

M H Bhat, V Sharma, F A Khan, Niyaz A Naykoo, S H Yaqoob, Ruby, H M Khan, M R Fazili, N A Ganai and R A Shah
Cryoletters (2013)
12. In vitro Development of Goat- Sheep & Goat- Goat zona- free cloned embryos in different culture media.

F A Khan, M H Bhat, S H Yaqoob, S M Waheed, Niyaz A Naykoo, H Athar, H MKhan, M R Fazili, N A Ganai, S K Singla, R A Shah
Theriogenology (2014) 81(3):419-23.
13. Association of interleukin 1 beta (IL-1β) polymorphism with mRNA expression and risk of non small cell lung cancer.

Imtiyaz A. Bhat, Niyaz A Naykoo, Iqbal Qasim, Farooq A. Ganie, Qaiser Yousuf, Bashir A. Bhat, Roohi Rasool, S.A. Aziz, Zafar A Shah.
Meta Gene (2014) 2: 123–133.
14. Possible Impact of RET Polymorphism and Its Haplotypic Association Modulates the Susceptibility to Thyroid Cancer
Khan MS, Pandith AA, Iqbal M, Naykoo NA, Khan SH, Rather TA, Mudassar S
J Cell Biochem (2015) 116(8): 1712-8.
15. Comparison between lignocaine hydrochloride and ropivacaine hydrochloride as lumbosacral epidural anaesthetic agents in goats undergoing laparoscopy assisted embryo transfer.
Anubhav Khajuria, Mujeeb ur Rehman Fazili, Riaz Ahmad Shah, Maajid Hassan Bhat, Firdous Ahmad Khan, Syed Hilal Yaqoob, Niyaz Ahmad Naykoo, Nazir Ahmad Ganai.
Mac Vet Rev (2014) 37 (2): i-ix.
16. Polymorphism in the CC-chemokine receptor-5 (CCR5) gene and risk of AIDS among Kashmiri population.

Syed Irtiza, Dil-Afroze, Niyaz A Naykoo, Lateef Charoo, Iqbal Qasim, Inayat S. Fazilia,Mir Aasif, Mushtaq A Siddiqi
Journal of AIDS and HIV Research (2011) 3(5), pp. 103-106.
17. Normal laparoscopic anatomy of the caprine pelvic cavity
Mujeeb ur Rehman Fazili, Riaz Ahmad Shah, Maajid Hassan Bhat, Firdous Ahmad Khan,
Anubhav Khajuria, Syed Hilal Yaqoob, Niaz Ahmad Naykoo, Nazir Ahmad Ganai.
Veterinary Science Development (2015) Vol 5, No 2
Uneeb Urwat, Inayat S .Fazili, Ruby, Touseef A.Rafiquee, F.D. Sheikh, Niyaz A. Naykoo, Firdous A. Malik, Riyaz A Shah, Nazir A. Ganai
Animal Science Reporter (2015), V 9(6)
19. IL 10 promoter polymorphism and gastric cancer risk in A+ve blood group patients in Kashmiri population.
Syed Irtiza, Niyaz A Naykoo, Imtiyaz A Bhat, Amat Us Samie, Dil-Afroze, Shakir Ali, Mushtaq A Siddiqi
International journal of genetics and molecular biology (2011) 3(8)
20. Single-nucleotide polymorphisms and haplotypes of vascular endothelial growth factor
Niyaz Naykoo, Dil Afroze, Roohi Rasool, A G Ahangar, Sonaullah Shah, Imtiyaz Bhat, Iqbal Qasim, Mushtaq A Siddiqi, Zafar A Shah
Gene Reports 8 (2017) 110–116
21. SNP and haplotype analysis of vascular endothelial growth factor (VEGF) gene in lung cancer patients of Kashmir
Niyaz A Naikoo1*, Dil-Afroze1, Roohi Rasool1 Sonaullah Shah2, A G Ahangar3, Imtiyaz A Bhat1, Iqbal Qasim4, Mushtaq A Siddiqi5, Zafar A Shah1* Asian Pac J Cancer Prev 18 (7) (2017) 1799-1804
22. Up regulation of vascular endothelial growth factor (VEGF), its role in progression and prognosis of non-small cell lung carcinoma
Niyaz A. Naikoo, Dil-Afroze, Roohi Rasool, Sonaullah Shah, A.G. Ahangar , Mushtaq A. Siddiqi, Zafar A. Shah
Cancer Genetics 216-217 (2017) 67–73

Dr. Hussien Abid Ali Bakir

Assistant Professor Faculty of Science Department of Physics University of Kufa Najaf Governorate, Iraq
B.Sc. in Medical Technology/Radiology Technology, Department of Radiology technology (2001) from College of Health and Medical Technology/Baghdad, Middle Technical University. M.Sc. in Medical Physics from College of Medicine, Branch of Physiology and Medical Physics, University of Al Mustansiriya (2005). Ph.D. in Medical Physics as Applied to Medical Imaging from University of Salford (United Kingdom/Manchester), School of Health Sciences, Department of Medical imaging and Radiography (2015). Working as a lecturer in the University of Kufa, Faculty of Science, and Department of physics from 2005 to recent.
1. Optimizing of radiation dose and image quality in diagnostic radiography/radiology using CR and DR.
2. Medical Image Quality assessment methods.
3. Quality Control/Assurance in diagnostic radiology.
4. Conducting theoretical and practical research in radiation protection fielded (health physics and diagnostic X-ray/Imaging).
5. Biological effects of radiation on human tissues/organs.
6. Developing and validating psychophysical systems to assess the image quality of diagnostic digital images
1) Junior associate at the The Abdus Salam International Centre for Theoretical Physics (2012).

Teaching Interests:
1. Medical Physics.
2. Radiological physics.
3. Radiation physics.
4. Nuclear medicine.
5. Radiation dosimetery.
6. Biophysics.
1. H. Mraity; A. England; I. Akhtar; A. Aslam; R. De Lange; H. Momoniat; S. Nicoulaz ; A. Ribeiro; S. Mazhir; P. Hogg, "Development and validation of a psychometric scale for assessing PA chest image quality: A pilot study", Radiography, 20 (2014) 312-317
2. Hussien A A B Mraity; Andrew England; Simon Cassidy; Peter Eeachus; Alexander Dominguez and Peter Hogg, "Development and validation of a visual grading scale for assessing image quality of AP pelvis radiographic images", British Journal of Radiology, 2016; 89: 20150430.
3 . H. Mraity ; A. England; P. Hogg, "Developing and validating a psychometric scale for image quality assessment", Radiography, 20 (2014) 306-311.
4. H. Mraity, A. England, P. Hogg. Gonad dose in AP pelvis radiography: impact of anode heel orientation. Accepted for publication in Radiography journal- Sciencedirect (2016).
5. Sana K, H. Mraity, A. England, P. Hogg. Lateral hip x-ray imaging – which technique produces lowest gonad dose combined with acceptable visual image quality?. Accepted for UKRC as poster last at July, 2013, Liverpool, UK.
6. Hussien Abid Ali Mraity, "Estimation of surface dose (skin absorbed dose) for the patient undergoing standards radiologic examinations", Journal of Kerbala University, 6 (2008) 260-259.
7. Hussien Abid Ali Mraity, "Calculation of skin absorbed dose for the staff and students from external gamma ray source in nuclear physics lab. Journal of Al-Qadisiyah for Pure Science 13 (2008) 116-125.
8. Hussien Abid Ali Mraity, "Study the effect of total filtration (filter thickness)of the x-ray tube on the surface dose for the patients undergoing standard radiologic procedures", Journal of Babylon University, 15 (2008) 580-584.
9. Hussien Abid Ali Mraity; Raed Mohammedkadhim; Abrar Mohammed Khuder, "Mathematical Calculation of Patient's Fluoroscopic Entrance Dose in Extracorporeal Shock Wave Lithotripsy", Journal of Kerbala University, 6 (2008) 117-127.
10. Hussien Abid Ali Mraity, Raed Moahammedkadhim, "Estimation of entrance skin exposure for patients undergoing fluoroscopic examination in extracorporeal shockwave lithotripsy(ESWL)", Journal of Kerbala University, 6 (2008) 173-176.
11. Hussien Abid Ali Mraity, "Estimation of patients effective dose while they are exposed for long time fluoroscopic examination in extra corporal shockwave lithotripsy(ESWL", Journal of Babylon University, 17 (2009) 565-568.
12. Hussien Abid Ali Mraity, Talib Abdularidha, Raed M, "Mathematical calculation of effective dose From gamma ray sources in nuclear physics lab.", Journal of AL-Qadisiya/Pure scienceUniversity, 14 (2009) 126-132.
13.Hussien Abid Ali Mraity, Muthana Hassan Hady, Raad Jaleel Ahmed, "Estimation of entrance skin exposure for pediatrics undergoing routine X-ray examination", Journal of Kerbala University, 7 (2009) 62-67.
14.Hussien Abid Ali Mraity, "Estimation of patients radiation dose undergoing conventional X-ray examination in Al-Hakeem general hospital(X-ray room(1))", Journal of Kufa -Physics- A special issue for Kufas first conference for physics, - (2010) 335-440.
15.Hussien Abid Ali Mraity, "Mathematical assessment of entrance surface dose(ESD) for patients examined by long term X-ray examination (fluoroscopy).", Journal of Kufa -Physics, 2 (2010) 2077-5830.
16.Hussien Abid Ali Mraity, "Mathematical calculation of skin and soft- tissues radiation absorbed dose from Na22 ,Ba133 and Cd109 radiation source for persons working in nuclear research room", Journal of Kerbala University, 8 (2010) 10-19.
17. Hussien Abid Ali Bakir, Raed Mohammed Kadhm, Calculation Of Pediatrics Entrance Surface Air Kerma (ESAK) Undergoing Fluoroscopic Examinations In Extracorporeal Shock wave Lithotripsy Unit. Journal of Babylon University.2010.
18. Ali Abid Abojassim, Suha H. Kadhim, Hussien Abid Ali Mraity and Rua R. Munim. Radon levels in different types of bottled drinking water and carbonated drinks in Iraqi markets, Water Science & Technology: Water Supply, 17.1(2017).
20. Determination of Radon Flux Density in Some Liquid of Cleaning Materials Samples in Iraq, Research J. Pharm. and Tech, 10(8),pp:1-5 (2017).

Book Chapters
1. Observer studies in mammography; P Hogg, S Millington, D Manning, and H Mraity- Book chapter in ‘digital mammography : A holistic approach’; P Hogg, J Kelly, C Merver, (2015).
2. Visual image quality assessment methods; Hussien Abid Ali Mraity and Maily Alrowily- Book chapter in ‘Mult icultural team-based research in radiogra phy , a holistic educational approach. Groningen, the Netherlands Edited by: Peter Hogg, Chr istine Blakeley and Car st Buissink (2016).

Róbert Novotný, MD

Institute for Clinical and Experimental Medicine Transplant Surgery Department Prague, Czech Republic
Employment history:

1. From 10/2011 10/2017: 2nd Clinic of Cardiovascular surgery, General Faculty Hospital in Prague, Czech Republic; Resident in Vascular Surgery
2. From 03/2015 -10/2017: 10% teaching load for the 1st Faculty of Medicine, Charles University, Prague at the General Teaching Hospital in Prague
3. From 10/2017-till present: Institute for Clinical and Experimental Medicine, Transplant Surgery Department, Prague, Czech Republic
Vascular surgery
Vascular transplants- fresh and cryografts
Societies Membership:

1. Czech society of Cardio Vascular Surgery - from 2014
2. Czech Society for Vascular Access - from 2014
3. European Society for Surgical Research - from 2017

Organizing Committees:
1. Member of the Organizing Committee of the 5th Symposium of Czech Society for Hemodialysis Access. Prague 2015, Czech Republic.
2. Member of the Organizing Committee-7th Congress of Czech Sociaty of Cardiovascular Surgery, 13th November-15th November 2015, Prague, Czech Republic
Review articles
1. Novotny R., Hlubocky J., Mitas P., Brlicova L., Lindner J.: Aortic valve sparing surgery: The use of the Coroneo Extra-Aortic Annuloplasty Ring. Med. Res. Arch. 2015, Vol.2; http://www.journals.ke-i.org/index.php/mra/article/view/61. DOI: http://dx.doi.org/10.18103/mra.v0i2.61
2. Novotny R., Hlubocky J., Mitas P., Lintner J.: Fibrin sealants in cardiac surgery – the last five years of their development, application. Adv. Clin. Exp. Med. Manuscript accepted for publication on 7.9.2016

Original articles
1. Lindner J., Amroz D., Novotny R., Niznansky M., Simkova I., Bohacekova M., Pecha O., Jansa P.: Pulmonary endarterectomy combined with cardiac surgery: A 7-year retrospective analysis. Cor et Vasa 2015; 57:e115-e120 (IF 0.110).
2. Novotny R., Brlicova L., Slavikova M., Valesova J., Mitas P., Hlubocky J., Lindner J. Arteriovenous graft used as a vascular access for hemodialysis: 15 years of experience. Chirurgia 2015;28:169-172.
3. Novotny R., Slavikova M., Hlubocky J., Mitas P., Hruby J., Lindner J. Basilic vein transposition used as a tertiary vascular access for hemodialysis: 15 years of experience. Open J. Cardiovasc. Surg. 2016; 8:1-4. doi: 10.4137/OJCS.S34837. eCollection 2016.
4. Novotny R., Slizova D., Hlubocky J., Krs O., Spatenka J., Burkert J., Fiala R., Mitas P., Mericka P., Spacek M., Lindner J.: Changes arising from different thawing protocols on cryopreserved human allograft’s aortic valve leaflets. Accepted for publication 27th March 20 7 Advances in Clinical and Experimental Medicine.
5. Novotny R., Slizova D., Hlubocky J., Krs O., Spatenka J., Burkert J., Fiala R., Mitas P., Mericka P., Spacek M., Lindner J. Cryopreserved human aortic root allografts arterial wall: structural changes occurring during thawing. PLoS One. 2017 Apr 17;12(4): e0175007. doi: 10.1371/journal.pone.0175007. eCollection 2017.
6. Hartinger J, Novotny R, Bilkova J, Kvasnicka T, Mitas P, Sima M, Hlubocky J, Kvasnicka J, Slanar O, Lindner J. Role of Dipyrone in the High On-Treatment Platelet Reactivity amongst Acetylsalicylic Acid-Treated Patients Undergoing Peripheral Artery Revascularisation. Med Princ Pract. 2018 May 13. doi: 10.1159/000489970.

Case Reports
1. Hruby J., Novotny R., Spacek M., Mitas P., Hlubocky J., Janak D., Povysil C., Lindner J.: Surgical extirpation of glomus tumor from rare localization on the upper extremity. Case Reports in Vascular Medicine, 2013; Article ID 570945, 3 pages. http://dx.doi.org/10.1155/2013/570945
2. Novotny R., Hruby J., Hlubocky J., Mitas P., Brlicova L., Valesova J., Janak D., Lindner J.: Giant paratracheal ancient schwannoma in 57-year-old male patient: case report. Eur. Surg. 2014; 47:35-38.
3. Janak D., Novotny R., Slavikova M., Grus T., Lindner J.: Complex surgical management of hemodialysis vascular access infection caused by Clostridium perfringens. Rozhl. Chir. 2014; 93:325-327.
4. Novotny R., Hlubocky J., Mitas P., Hruby J., Spacek M., Spunda R., Tosovsky J., Lindner J.: Iatrogenic post-catheterization radial arteriovenous fistula in 64-old male patient. J. Imag. Intervent. Radiology. 2015. Vol.2, No. 1:17.
5. Novotny R., Mitas P., Hlubocky J., Hruby J., Slautin A., Spunda R., Lindner J.: Juxtarenal modular aortic stent graft infection caused by staphylococcus aureus. Case Rep. Vasc. Med. 2016:7597265. doi: 10.1155/2016/7597265. Epub 2016 Jan 24.
6. Novotny R., Lesensky J., Hruby J., Hlubocky J., Mitas P., Lindner J.: Chondrosarcoma resection followed by a branched crural revascularization of the right Calf: Case Report. Vasc. Med. Case Reports. Cor et Vasa DOI: 0.1016/j.crvasa.2016.02.005
7. Novotny R., Hlubocky J., Kovarnik T., Mitas P., Hlubocka Z., Rulisek J., Gulmez S.I., Ghotra S.K., Lindner J.: Failed TAVI in TAVI implantation: TAVI dislocation followed by ensuing surgical graft resection. Case Reports in Cardiology
Volume 2017, Article ID 5086586, https://doi.org/10.1155/2017/5086586
8. Slautin A., Mikulenka V., Hlubocky J., Novotny R., Spacek M., Vondracek V., Lindner J.. Ruptured non-coronary sinus of Valsalva aneurysm into the right atrium in 44-year-old patient: Case report.Cor et Vasa, http://doi.org/10.1016/j.crvasa.2017.01.007
9. Novotný R., Mitáš P., Hlubocký J., Grus T., Svobodová A., Slautin A., Hlubocká, Z. Lindner J.: Surgical resection of occluded abdominal stentgraft followed by aorto-bi-iliac vascular reconstruction with intergard synergy vascular prosthesis. Cor et Vasa DOI 10.1016/j.crvasa.2017.11.003
10. Novotny R, Maly S, Lipar K, Chlupac J, Janousek L, Fronek J. Open repair of a symptomatic popliteal artery aneurysm in a 71-year-old patient: Case report, Cor et Vasa (2018), https://doi.org/10.1016/j.crvasa.2018.03.001
11. Novotny R, Marada T, Chlupac J, Viklicky O, Fronek J. Simultaneous Living Donor Orthotopic Renal Transplantation and Bilateral Nephrectomy for Recurrent Renal Cell Carcinoma and Renal Failure: Case Report and Review of Literature. Research and Reports in Urology. Accepted for publication 7th Martch 2018

Michael A. B. Naafs, PhD

Dutch Internist-Endocrinologist Health Consultant at Naafs,International Health Consultancy Rhodoslaan 20, 7577KN, Oldenzaal, Netherlands
Michael A.B. Naafs is a Dutch internist-endocrinologist with a long clinical career in internal medicine and endocrinology .
His PhD Endocrinology was obtained at Leiden University (1988) and focused on the renal end-organ resistance to PTH (Parathormone) infusion in normo-and hypercalcaemic patients with solid tumors secreting a PTH-like factor.
Other area’s of interest are clinical pharmacology where he was in the front of clinical research of transdermal nitroglycerin patches.(1984) Recently he participated in the standard book project “Drug Discovery and Evaluation: Methods in Clinical Pharmacolgy “Eds Hock.F.J,Gralinski M.R 2nd Edition, 2017, Springer Verlag, providing the section “Pharmacodynamic Evaluation: Endocrinology “.
In infectious medicine he was one of the first to report about HIV-2 infection (1990) Experience in HIV,MDRTB and tropical Infectious medicine was acquired during a one year stay at Nelson Mandela Academic Hospital,Umthata,South Africa.( 2008).
At present he works as an independent health consultant (Naafs International Health Consultancy ) and as a Medical Writer. Michael is an editorial board member of a number open access journals and the author of tenfolds of publications.
1. The urinary excretion of camp in patients with malignant tumors. P.C. van der Velden, M.A.B. Naafs, H.R.A. Fischer, W.H.L. Hackeng, G. Koorevaar, W. Schopman, J. Silberbusch. Neth. J. Med. 1983; 26: 10-17.
2. Renal clearance of digoxin in man after sodium loading or furosemide treatment. M.A.B. Naafs, C. van der Hoek, W. Schopman, S. van Duin, G. Koorevaar, J. Silberbusch. Eur. J. Clin. Pharmacol. 1983; 25: 375-379.
3. Histamine en parathyroid activity. P.C. van der Velden, M.A.B. Naafs, J.H. Paulusma & de Waal, J. Silberbusch. Horm. Metab. Res. 1984; 16: 269-270.1.
4. Changes in nephrogenous cyclic AMP excretion and plasma cyclic AMP following treatment of hyperthyroidism. M.A.B. Naafs, P.C. van der Velden, H.R.A. Fischer, G. Koorevaar, S. van Duin, W.H.L. Hackeng, W. Schopman, J. Silberbusch. Acta Endocrinol. (Copenh.) 1984; 106: 477-481.
5. Exercise capacity with transdermal nitroglycerin in patients with stable angina pectoris. M.A.B. Naafs, A.C. de Boer, R.W. Koster, C.W. Klazen, A.J. Dunning. Eur. Heart J. 1984; 5: 705-709.
6. Acutesuppuratievethyreoiditis. M.A.B. Naafs, H.R.A. Fischer, E.E.J. Ligtvoet, J. Silberbusch. Ned. Tijdschr. Geneeskd. 1985; 1292-1293.
7. Decreased renal clearance of digoxin in chronic congestive heart failure. M.A.B. Naafs, C. van der Hoek, S. van Duin, G. Koorevaar, W. Schopman, J. Silberbusch. Eur. I. Clin. Pharmacol. 1985; 29: 249-252.
8. Influence of pharmacological doses of calcitonin on serum B2 microglobulin concentration. H. Mulder, H. van Bolhuis, M.A.B. Naafs, P.L.M. Winckers. Calcif. Tissue Int. 1985; 37: 367-371.
9. End-organ resistance to PTH-infusion in hypercalcaemic and normocalcaemicpatiente with solid tumours. M.A.B. Naafs, H.R.A. Fischer, P.C. van der Velden, H. Mulder W.H.L. Hackeng, W. Schopman, G. Koorevaar, J. Silberbusch. Acta Endocrinol. (Copenh.) 1986; 113: 543-550.
10. Een nonogram voor dosisbepaling van digoxine voor bejaarde patienten met boezemfibrileren. M.A.B. Naafs, J. Silberbusch. Ned. Tijdschr. Geneeskd. 1987; 507.
11. Once a week high dose thyroid hormone replacement therapy in a hypothyroid patient. M.A.B. Naafs, H.R.A.Fischer, P.P.M. Bender: J. Silberbusch. Neth. J. Med. 1987; 30: 187-192.
12. Changes in serum osteocalcin following treatment of mild hyperthyroidism. M.A.B. Naafs, A.C. de Boer, H.R.A. Fischer, W.H.L. Hackeng, Silberbusch. Neth. I. Med. 1987; 31: 52-57.
13. The effect of age on the renal response to PTHinfusion. M.A.B. Naafs, H.R.A. Fischer: G. Koorevaar, W.H.L. Hackeng, W. Schopman, J. Silberbusch. Calcif. Tissue Int. 1987; 41: 262-266.
14. Abnormal responsiveness of nephrogenous cyclic AMPexcretion following intravenously administered calcium in normocalcaemic squamous cell cancer patients. M.A.B. Naafs, W.H.L. Hackeng, G. Koorevaar, J. Silberbusch. Bone and Mineral 1988; 4: 289-298.
15. Predicted and actual clinical potency of a new third generation bisphosphonate. O.L.M. Bijvoet, K. Hoekman, M.A.B. Naafs, S.E. Papapoulos. J. Bone Min. Res. 1988; 3: S 129.
16. De invloed van veranderingen in de concentratie van het serum parathyreoid hormoon op de responspatronen van de nier. 1. M.A.B. Naafs Academisch proefschrift. Leiden, 7 december 1988.
17. Acute pancreatitis in a case of Werner’s syndrone with severe hyperlipidaemia. M.A.B. Naafs, H. Schouwink, G.G. Roeleveld, E.H. Slaats, J. Silberbusch. Neth. J. Med. 1989; 34:4: 194-200.
18. The influence of transdermal estradiol on PTH-release in postmenopausal women with primary hyperparthyroidism. W.M. Smit, M. Louwers, E.H. Slaats, M.A.B. Naafs, J. Silberbusch. Calcif. Tissue Int. 1989; 44: S 26.
19. De pathogenese van het humorale hypercalciemie syndroom bij patienten met een solide tumor. M.A.B. Naafs, J. Silberbusch. Ned. Tijdschr. Geneeskd. 1989; 21: 1065-1069.
20. Aggravation of hypoglycaemia in insulinoma-patients by the longacting somatostatin analogue Sandostatin. C.D.A. Stehouwer, W.F. Lems, H.R.A. Fischer, W.H.L. Hackeng, M.A.B. Naafs. Acta Endocrinol. (Copenh.) 1989; 121: 34-40.
21. The influence of transdermal estradiol on PTH-release in postmenopausal women with primary hyperparathyroidism and in osteoporosis. W.M. Smit, E.H. Slaats, M.A.B. Naafs, C.L. van Schaik, I. Silberbusch. J. Bone Min. Res. 1989; 4: s: 172.
22. The usefulness of an oral calcium tolerance test in the management of patients with idiopathic hypercalciuria. M.A.B. Naafs, E. Essed, W.H. Hirdes, W.H.L. Hackeng, H.R.A. Fischer. Neth. J. Med. 1990; 36: 223-227.
23. HIV-2 Infectie bij een in Nederland wonende Portugese vrouw met een AIDS dementiecomplex. J. Nouwen, J. Buitenwerf, A.M. Boelmans-Kranenburg, H. Geldof, M.A.B. Naafs. Ned. Tijdschr. Geneeskd.. 1990; 134:1: 26-28.
24. Pijn in een arthrotische heup; niet altijd ‘oud nieuws’. J.W. Manten, A.J.W. Marsman, H.L.M. Brus, M.A.B. Naafs. Ned. Tijdschr. Geneeskd. 1994; 49: 2425-2427.
25. CIOP in adolescents treated for pulmonary disease. M.A.B. Naafs, Poster presentation 25th European Symposium on Calcified Tissues Harrogate UK 1997
26. Snelle fractuurbescherming van risedronaat nu ook beschikbaar in wekelijkse dosering . M.A.B. Naafs. Modern Medicine 2003; 3; 233-34
27. Het antifractuureffect van risedronaat is groter dan dat van nasal calcitonine en alendronaat. M.A.B. Naafs. Modern Medicine 2003; 9; 680-81
28. Michael AB Naafs.,2017, Pharmacodynamic Evaluation: Endocrinology,Chapter 35; doi: 10.1007/978-3-319-56637-5_35-1.
29. Drug Discovery and Evaluation: Methods in Clinical Pharmacology, 2nd Edition, Editors Hock F.J, Gralinski M.R. Springer Verlag Berlin ,Heidelberg,New York.
30. Michael AB Naafs,2017, Clinical Pharmacodynamics of Endocrine Disruptors:A Historic Perspective. Endocrinol.Diabetes Res. 2017;4;(1);1000128.
31. Michael AB Naafs, 2018. Antimicrobial Properties of Copper and Copper Alloys in Infection Control. InfectionControl.tips; 2017;Aug 9; www.IC.tips .
32. Michael AB Naafs, 2017. Pheromones: Honey’s and Queens. Glob.J.Otolaryngol.,2017;9;(5);555775;DOI 10 19080/GJO 2017,09.555 775.
33. Michael AB Naafs,2017. The Maggots: Professional Wound Cleaners. InfectionControl.tips: 2017; Oct 31, www.IC.tips.
34. Michael AB.Naafs,2017. The Antimicrobial Peptides : Ready for Clinical Trials ? Biomed.J.Sci.&Tech.Res ,BJSTR,2018;MS.ID.001596;doi:1026717/BJSTR.2018.07.001536.
35. Michael AB Naafs,2017. Second Messengers in Endocrinology: A Mini-Review of the Cyclic Nucleotides. Endocrinol. Metabol. Int. J. 2017; 5(6);00144.DOI:10.15406/emij.2017.05.0144.
36. Michael AB Naafs, 2017. Hypocalcemia in the Critically Ill: A Mini –Review. Endocrinol.Metab.Int.J. 2017;5(4);00130;DOI:10.15406/emij.2017.05.00130.
37. Michael AB Naafs, 2017. Aspiration and Swallowing in Parkinson’s Disease:Two Hundred Years Later. Glob.J.Otolaryngol.. 2017;10(3);555789;DOI 10.19080/GJO 17.10.555789.
38. Michael AB Naafs,2017. Parathyroid Hormone-Related Peptide (PTHrP); A Mini-Review. Endocrinol.Metab.Int.J. 2017;5(6);00139; DOI:10.15406/emij 2017.05.00139.
39. Michael AB Naafs, 2017. Cavernous Sinus Thrombosis in ENT Practice. Glob.J.Otolaryngol. 2017.:10(5);GJO.MS.ID 555798;DOI:10.19080/GJO.2017.10.5
40. Michael AB Naafs,2017, MinimallyInvasive Parathyroidectomy in Primary Hyperparathyroidism: A Mini-Review.
41. Glob.J. Otolaryngol.. 2017;12(2);555831.DOI:10.19080/GJO.2017.12.555831.
42. Michael AB Naafs,2017, Measurement of the Anti-Müllerian Hormone in Clinical Endocrinology: A Mini-Review.
43. Invest.Gynecol.Res.&Women’s Health 2017;1(2);IGRWH 00509.
44. Michael AB Naafs,2017. Lugol’s Solution in Thyroid Surgery: A Mini-Review. Glob.J.Otolaryngol. 2017;11(4);555817;Doi 10-19080/GJO 2017.11555817.
45. Michael AB Naafs,2018. Calcitonin-Gene Related Peptide (CGRP) in Pain and Migraine: A Mini-Review. Endocrinol. Metab.Int.J. 2018;6(2);130-135;Doi:10.15406/emij.2018.06.00166.
46. Michael AB Naafs,2018. Labyrinthitis Vestibular Neuritis, And Sensorineural Hearing Loss(SNHL).,2018. Glob.J.Otolaryngol. 2018,Doi:10.19080/GJO.2018.15.555914.
47. Michael AB Naafs,2018. The Fetal Alcohol Spectrum Disorders. Int Gyn.& Women’s Health.,2018;1(2);IGWHC MS.ID.000109.
48. Michael AB Naafs 2018. The Burden of Allergic Rhinitis: A Mini-Review. Glob.J.Otolaryngol. 2018;13(1);555854;DOI:10.19080/GJO.2018.13555854.
49. Michael AB Naafs,2018. Child Abuse and Addiction in Obesity. Invest.Gynecol Res.& Women’s Health 2018;2(2);IGRWH 000534.2018;DOI:10.31031/GRWH.2018.02.000534.
50. Michael AB Naafs,2018. Selective Androgen Receptor Modulators (SARMs): A Mini-Review. Open Acc/Repro &Sexual Disord:1(1)-2018 OAJRSD.MS ID.000103
51. Michael AB Naafs,2018. Microbial Endocrinologyin Microbiology: A Mini-Review. Int.J. Clin.Endocrinol. 2018;2(1);004-010.
52. Michael AB Naafs,2018. Glucocorticoid Chronotherapy: A Mini-Review. Endocrinol.Metab. Int. J. 2018; 6(2);118-122;Doi:10.15406/emij.2018.06.00164.
53. Michael AB Naafs, 2018. Oral Mucosal Immune Suppression,Tolerance and Silencing: A Mini-Review. Mod.App.Dent.OralHealth&Care 2018;1(2);MADOHC;MS.ID.000.109.
54. Michael AB Naafs,2018. The Global Impact of the Mo-99 Shortage Biomed. J.Sci.&Tech. Res. 2018;4(5);MS.ID 0001114;Doi:10.26717/BJSTR 2018.04001114.
55. Michael AB Naafs,2018- Ultra-Processed Foods,GutHealth,Autoimmunity and Diets. CPQ Medicine,2018;2(2);01-12.
56. Michael AB Naafs,2018. The Vasopressin V2 Receptor Antagonists: The Vaptans. Glob. J. Endocrinol. Metab. 2018;2(1);GJEM.000529.2018.
57. Michael AB Naafs,2018. Human Growth Hormone Therapy Int.J.Clin.Endocrinol. 2018;2(1);011-018.
58. Michael AB Naafs,2018. Some of World’s Largest Legionella and Q Fever Outbreaks in a Small Country:Co-Incidence? CPQ Medicine 2018;2(4);01-03.
59. Michael AB Naafs,2018. MetabolicLiver Inflammation in Obesity. CPQ Medicine 2018;1(2);01-17.
60. Michael AB Naafs,2018. Tongue Tie and Breastfeeding: Of the Gap or Another Hype? Mod.App.Dent. Oral Health&Care,2018; 2(4);MADOHC.M.ID.000.142.
61. Michael AB Naafs,2018. Occupational Diseases in the Petrochemical Sector and Offshore Upstream Petroleum Industry. Progress Petrochem. Sci. 2018;2(2);PPS.000.535.2018
62. Michael AB Naafs,2018. Dental DNA Fingerprinting. Mod.App.Dent. Oral Health&Care 2018;2(4);MADOHC.MS.ID.000.143.
63. Michael AB Naafs,2018. Congenital Syphillis: On the Rise Again. Gynaecology&Perinatology (GYPE),2018;2(3);273-80.
64. Michael AB Naafs,2018. Errors in the Total Testing Process (TTP) of Microbiological Samples. CPQ Medicine 2018;1(6);01-07.
65. Michael AB Naafs,2018. Exposomics and Growth Rings in the Teeth. Mod.App.Dent. Oral Health&Care 2018;2(4;MADOHC.MS.ID.000.145
66. Michael AB Naafs, 2018. Persistent Wound Leakage After Total Knee and Hip Arthroplasty. Orthop.&Spo. Med. Op. Acc. J.2018;1(4);2018,OSMOAJ;MS.ID.000116.
67. Michael AB Naafs, 2018. Sensor Technology Developments in Diabetes Monitoring. CPQ Medicine 2018:2(1);01-14
68. Michael AB Naafs,2018. New Insights intoInflammation in Atherosclerosis. Glob.J.Endocrinol.Metab. 2018; 2(4);GJEM.000547.2018;Doi:10.31031/GJEM.2018.02.000547.
69. Michael AB Naafs,2018. Minimal Effect But No Cure For Alzheimer’s with Antidiabetic Drugs. Clin.J.Dia.Care&Control,2018;1(2);18006.
70. Michael AB Naafs, 2018. Is Tauism Dead? Degener.Intell.Develop. Disabilities.,DIDD, 2018:1(4);1
71. Michael AB Naafs,2018. Nutrition and Hearing Loss. Glob.J. Otolaryngol., 2018;18(5);GJO;Ms.ID 555948
72. Michael AB Naafs, 2018. Fitness and Sports After Total Joint Arthroplasty. Journal of Physical Fitness,Medicine and Treatment in Sports (JPFMTS).2018;4(5);JPFMTS;MS.ID 555650
73. Michael AB Naafs,2018. Women’s All Causes Death and Alzheimer’s Disease: An Editorial. CPQ Medicine 2018;2)4);01-04.
74. Michael AB Naafs,2018. Fungal Infections in Gastroenterology. Curr.Tr..Gastr.&Hepatol. 2018;1(3);CTGH;MS.ID.000114.
75. Michael AB Naafs,2018. Shockwave Therapy in Atherosclerosis. LOJ.Med.Sci.2018;1(2);LOJMS.MS.ID.000106.
76. Michael AB Naafs,2018. Is Online Transgender Healthcare The Future? Open Access Repro. & Sexual Disorders 2018:1(4); OAJRSD:MS.ID.000116
77. Michael AB Naafs,2018. FDA Approvals of Medical Devices Under the De Novo Automatic Class 3 Regulations.
78. Biomed.JSci.&Tech.Res. 2018;BJSTR.MS.ID.001623;DOI:10.26717/BJSTR 2018.08.001623.
79. Michael AB Naafs,2018. Lipedema:Therapy Evaluation and Insurance. CPQ Medicine 2018;2(6);01-08.
80. Michael AB Naafs, 2018. Herd Immunity:A Realistic Target?Biomed.J.Sci&Tech.Res.2018;9(2);BJSTR.MSID.001779;Doi:10.26717/BJSTR.2018.09.001779.
81. Michael AB Naafs,2018. Hurricanes,Floods and Ritual Infectious Disease Outbreak Warnings. CPQ Medicine,2018,:3(1);01-11
82. Michael AB Naafs,2018. Vascular Complications of Parapharyngeal Abscesses. Onlne Journal of Otorlaryngology and Rhinology2018,in press.
83. Michael AB Naafs,2018. Klinefelter Syndrome and Fertility Preservation. Reproduction&Sexual Disorders International Journal 2018,in press
84. Michael AB Naafs, 2018. The Effect of Fitness,Sports,and Lifestyle Factors on All Causes Mortality and Insurance Premiums. Journal of Sports,Science and Physical Therapy. 2018,JSSPT;102.
85. Michael AB Naafs,2018. New developments for Gout. CPQ Medicine,submitted for publication.
86. Michael AB Naafs, 2018. Developments for the Greater Trochanteric Pain Syndrome (GTPS). J.Sports.Sci.PhysicalTher.;submitted for publication.
87. Michael AB Naafs,2018. NovelHyperkalemia Drugs. CPQ Medicine,2018,submitted for publication.
88. Michael AB Naafs,2018. Thrombocytopenia in Chronic Liver Disease: New Developments. Curr.Tr.Gastr. &Hepatol. 2018; submitted for publication
89. Michael AB Naafs,2018. Curcumin and Food Nanotechnology. CPQ Medicne,2018,submitted for publication.
90. Michael AB Naafs,2018. Medical Benefits of Coffee and Tea. EBook,JuniperPublishers,in preparation.

Alejandro de la Vega, MD

School of Medicine, Cordoba National University Neuquén, Córdoba, Argentina
1991 – 1998 Doctor of Medicine. School of Medicine, Cordoba National University, Córdoba, Argentina.

Health Care Activity
06-2012 – present: Part- Time Doctor at Angiography and Hemodynamics Services at Río Negro and Neuquén Medical Foundation.
06-2012 – present: Chief of Vascular Diagnostic Area through MRI (magnetic resonance imaging) and MSCT (multi-slice computed tomography) at Río Negro and Neuquén Medical Foundation. Cipolletti, Argentina.
2005 – present: Chief of Cardiovascular Diagnostic Area through MRI (magnetic resonance imaging) and MSCT (multi-slice computed tomography) at Clínica de Imágenes S.A. (Imaging Clinic). Neuquén, Argentina.
06-2004 – present: Doctor at Diagnostic Imaging Department in Clínica de Imágenes S.A. (Imaging Clinic). This outpatient facility assists over 5000 patients monthly (Complexity A- type 7). Neuquén, Argentina.
06-2004 – present: Doctor at Diagnostic Imaging Department in Río Negro and Neuquén Medical Foundation. This medical center with admission assists over 5000 patients monthly (Complexity A- type 1). Cipolletti, Argentina
Honors and Prizes
09-2008: Second Prize – Interest in Angio-NMR and Multi-slice Angio-CT in long-term monitoring of thoracic aorta endograft. Authors: Alejandro de la Vega, German Girela, Hernan Bertoni, Alejandro Schroeder. Clínica de Imágenes (Imaging Clinic)/ Instituto Cardiovascular del Sur (Southern Cardiovascular Institute). 54º Congreso Argentino de Radiología, Diagnóstico por Imágenes y Terapia Radiante (54th Argentinian Congress of Radiology, Diagnostic Imaging, and Radiotherapy). Buenos Aires, Argentina.
09-2006: “CUM LAUDE” Award for Electronic Poster: “Aortic Dissection: Diagnosis and Post-Therapeutic Follow-up through NMR”. 52nd Argentinian Congress of Radiology, Diagnostic Imaging, and Radiotherapy). Buenos Aires, Argentina.
1. Bertoni H.G., Azzari F.A., Girela G.A., Salvo G.A., de la Vega A., Romero G.A., Bourques N., Charask A.A., LeguizamónJ.H. Oclusión Intencional de la arteria subclavia izquierda durante el tratamiento endovascular de la aorta torácica descendente ( Intentional Occlusion of the Left Subclavian Artery during the Endovascular Treatmeant of the Descending Thoracic Aorta). Rev Argent Cardiol 2011;79:21-26.
2. Bertoni H.G., Girela G.A., Peirano M., LeguizamónJ.H., de la Vega A., Barone H.D., Nutley M., Zhang Z., Douville Y., Guidoin R. A Branched, Balloon-Deployable, Aortomonoiliac Stent-Graft for treatment of AAA in a Patient With a Solitary Intrapelvic Kidney. Journal of Endovascular Therapy 2010;17:000–000.
3. de la Vega A., Urdiales P., Pereyra J., Schroeder A. Acute Myocardial Infaction and Complication of Non-calcified Plaque in Left Anterior Descending Coronary Artery.Somatom Sessions. Issue N° 21/November 2007. RSNA-Edition. Siemens medical-magazine.
4. Boussel L., Herigault G., de la Vega A., Nonent M., Douek P., Serfaty J.M.Swallowing, arterial pulsation, and breathing induce motion artifacts in carotid artery MRI.2003Journal of Magnetic Resonance Imaging. Volume 23. Issue 3: 413-415.
5. Serfaty J.M., Nonent M., Nighoghossian N., Rouhart F., Derex L., Rotaru C., Chirossel P., Thabut G., Guias B., Heautot J.F., Gouny P., de la Vega A., Pachai C., Ecochard R., Villard J., Douek P., Plaque density on CT, a potential marker of ischemic stroke. for the CARMEDAS Study Group. Neurology 2006;66:118-120.
6. Wolff L., Azuly G., Pfister M., Florenzano N.V., de la Vega A., Serini V. Invaginación intestinalen un paciente. Diagnóstico mediante la utilización de Tomografía y Ultrasonido. Correlación Radiológica-Quirúrgica-Patológica (Intussusception in a Patient. Diagnosis by means of Tomography and Ultrasound. Radiological, Surgical and Pathological Correlation) Revista Argent. Radiol 66:2002, 159-165.
7. de la Vega A., Mondello E., Eyheremendy E.P. “Lupus Profundo (Paniculitis Lúpica) Hallazgos imagenológicos en una paciente” (Deep Lupus (Lupus Panniculitis) Imaging Findings in a Patient. Revista Argent. Radiol., 2002.
8. de la Vega A., Mondello E., Eyheremendy E. Neoplasia epitelial papilar y sólida de páncreas en una adolescente (Papillary and Solid Epithelial Neoplasm of the Pancreas in a Teenager). Revista Argent. Radiol N° l Vol. 65, 2001.

Giulio Tarro

Adjunct Professor Department Biology, Temple University, College of Science and Technology Philadelphia, PA 19122, USA Chairman Committee Biotechnologies and VirusSphere, World Academy Biomedical Technologies UNESCO, Italy
Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President Foundation de Beaumont Bonelli for Cancer Research. His basic researches have been concerned with antigens induced early during the replication cycle of human herpesviruses. Another study has involved the identification, isolation and characterization of specific virus-induced tumour antigens, which were the "finger-prints" left behind in human cancer.Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.

Who’s Who in America
Who’s Who in the World

TARRO, GIULlO, virologist; b. Messina, Italy, July 9, 1938; s. Emanuele and Emanuela (Iannello) Tarro; 1 adopted child, Giuseppe. MD, U. Naples, 1962, postgrad. in nervous diseases, 1968, PhD in Virology, 1971; postgrad. in med. and bioI. scis., Roman Acad., 1979; degree in medicine (hon.), U. Pro Deo, Albany, NY, 1989; degree in immunology (hon.), St Theodora Acad., NY, 1991; degree in bioethics (hon.), Constantinian U., Cranston, RI, 1996; MSc in Biomed. Techs. (hon.), ASAM U., Rome, 2008; degree in Social Scis. (hon.), Bonake U., Abidjan, Cote d'Ivoire, 2010. Asst. in med. pathology Naples U., Italy, 1964-66; rsch. assoc. divsn. virology and cancer rsch. Children's Hosp., Cin., 1965-68; asst. prof. rsch. pediat, U. Cin. Coil. Medicine, 1968-69; rsch. fellow Nat. Rsch. COUll., Naples, 1966-74, rsch. chief, 1974; prof. oncologic virology Call. Medicine U. Naples, 1971-85, prof. microbiology and immunology Sch. Specialization, 1972-2006; chief divsn. virology D. Cotugno Hasp. Infectious Diseases, Naples, 1973-2006, pres. ethic com., 1998-2007, head dept. diagnostic labs., 2003-06, emeritus, 2006-. Sr. scientist Nat. Cancer Inst. Frederick Ctr., Md., 1973; project dir. Nat Cancer Inst., Bethesda, Md., 1971-75; edn. min. rep. Zool. Sta., Naples, 1975-79; cons. Italian Pharmacotherapic Inst., Rome, 1980-98, med. dir., 2006-07; nat. com. on bioethics, 1995-98; ethics com. Basilicata Oncologic Hosp., 2005-13; pres. De Beaumont Bonelli Found. Cancer Rsch., Naples, 1978-, European Group Econ. Interest, Rsch, and Devel., Naples, 2003-07, Campania Tech. and Ecology Ctr., 2004-12; dean faculty natural and phys. sets. Nobile Accademia di Santa Teodora Imperatrice, 1993-2003; dept. head medicine Naples People U., 2000-05; sci. coord. extracorporeal hyperthermia in HCV patients First Circle Med., Mpls., 2000-03; vice chmn., gen. sec. sci. adv. bd. Unihart Biotech Pharm., London, 2005-07; chmn. com. on biotechs. and virusphere World Acad. Biomed. Techs., UNESCO, Paris, 2007-; adj. prof. dept biology Temple U. Call. Sci. and Tech., Phila., 2007-, pres. sci. com. Moravia U. Gonzaga Inst. Naples, 2008-09, pres. Norman Acad. Rome, 2009-. Nat com. On health, 2013. Author: Virologia Oncologica, 1979, Patologia dell'AIDS, 1991, Can iI Cancro si PUG Vivere, 1992, AIDS Cosa Possiamo Fare Cosa Dobbiamo Sapere, 1994, Pocket File Research Collection, 1997, 6th edit., 2003, To Prevent Is To Win, 1998, Bioethics and Culture of Prevention, 2001, Health Without Borders, 2004, 5th edit., 2012, Safety No Limits, 2008, Campania Land of Poisons, 2012, Medicine is Life; 2013; editor-in- chief: Internal. Jour. Clin. Investigation, 2000-10, Cotugno News, 2003-09, Fratres, 2004-; Journal of Vaccine and Development, 2015 -; contbr. more than 490 articles to profl. jours.Pres. Sci. Cultural Com., Torre Annunziata, Italy, 1984, Tumor Prevention Assn., Rome, 1984; mem acad senate Constantinian U., Providence, 1990, U. Pro Deo, NY, 1994; hon. acad U. Sancti Cyrilli, Valletta, Malta, 2001; mem UNESCO-Hebrew U. Jerusalem Internat. Sch. Molecular Biology and Microbiology, hon. rector Ruggero II U., Fla., 2003, pres., 2013-. Maj. Italian Navy, 1982-84, Lt. col., 1993-95, mem UN Internat. Computing Sci. Acad., 1997, mem Lions Found., 1990-91 Decorated comdr, Nat. Order of Merit, Star of Europe, knight grand cross Sovereign Constantinian Order St, George, gt officer Italian Republic; recipient Internal. Lenghi award Lincei Acad., 1969, Gold Microscope award Italian Health Min., 1973, Knights of Humanity award Internat. Register of Chivalry, Malta, 1978, Gold medal of culture Pres. Italian Republic, 1975, Culture award, 1985,1st prize in biomed. rsch., Italian Acad. Arts and Scis., 1987, Castello di Pietrarossa award, Italy, 1991, Gold Cesare award Padova, 1991, Gold Little Horse, Transnat. European Fedn., Rome 1996, King Manfredi award and Silverplate Pres. Italian rep. Manfredonia, 1999, Equestris Ordinis S. Sepulcri of Ierusalem, Rome, 1999, Gold medal of health Pres. Italian Republic, 1999, Saint Catherin award, Siena, 2003, Sorrento in the World award, 2004, Medal of Culture Ministry, 2005, Knight of Solidarity Internat. award Norman Acad .• Rome, 2006, hon. pres. 2009-, st. Pia for Peace award City of Fiuggi, 2006, Tables of Law award Internal. Assn. Cath. Apostleship, Naples. 2006, 32nd -Casentino lnternat. award in medicine Poppi-Arezzo, 2007, Grand Cross-Internat. Acad. State
Wyo., 2008, award Pres. Italian Rep, Silver medal, 2004, 2008, Lifetime Achievement award, Sbarro Health Rsch. Orgn.Phila., 2009, Nat. award for solidarity Fratres St. Giovanni La Punta, 2010, Global Edn. Sanremo award, 2011. Internal. Peace award, 2011, Grand Prix Solidarite Dem. Rep. Congo, 2010, Gold medal, Norman Acad., Rome, Internat, prize, Le Muse, Florence, 2012, Gold medal for 50 Yrs. MD, Rilancio Italia award, Rome, 2013, Knight Grand Cross Cernetic Imperial Order, Belgrade, 2013. Fellow: AAAS; mem.: Internat. Soc. Neurovirology, Tu es Petrus (Vatican City) (sci. com. mem.), Royal House Aranan (Philippine) (Gold medal 2012), Am. Chern. Soc., European Soc. Clin. Virology, NY Acad. Scis., Nat. Order Journalists, AIDS Sac. Asia and the Pacific, Assn. Res. Prevention of Cancer (sci. com. 1995), Italian Assn. Viral Study and Rsch, (pres. 1995-2008, hon. pres. 2009-), Italian Soc. Immuno-Oncology (v.p. 1975-, pres. 1990-2008), Internat. League Drs. for Abolition of Vivisection (pres. 1992-2012), Internat. Assn. Leukemias, Am. Assn. Cancer Rsch., Am. Soc. Microbiology (people to people amb to South Africa 2010), Acad. History Sanitary Art (hon.), Rotary, Lions (pres. Pompei chpt. 1987-89, pres. com. fight cancer 1989-90, vice gov. dist. 1991-92, pres. com. fight cancer 1992-94, pres. com. sci. and life 1994-95, pres. com. fight drug addiction and AIDS 1995-97. pres. com. transplant and donations 1998-99, pres. com. oncology 2000-02, pres. com. on stem cells 2002-03, dist. dir. operative area ethics and social solidarity 2003-04, pres. Pompei chpt. 2004-06, dist. dir. operative area health and rsch. 2006-14, dist. dir. rare diseases 2014-15, LISC Internat dir. 2012-14, Melvin Jones fellow 1993,2004,2008,2010, 1995). Roman Catholic. Achievments include patents in fieldof first link-at-viruses to human cervical cancer; discovery ofRSV virus in infant deaths in Naples and of tumor liberated protein as a tumorassociated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas. Flu virus expert 2015 (OMICS Group). Home Via Posillipo 286 80123 Naples NA Italy
His basic researches have been concerned with antigens induced early during the replication cycle of human herpesviruses.
Another study has involved the identification, isolation and characterization of specific virus-induced tumour antigens, which were the “finger-prints” left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.
Awards and Honors
• 1963 Lepetit Award for Medical Degree, University of Naples
• 1965, 1966 "A. B. Sabin" Prize (U.S. dollars 3,000 each) from SCLAVO Institute, Siena
• 1967 U.S. dollars 5,000 Award from Italian Pharmacotherapic Institute
• 1969 "G. Lenghi" International Award of the National Academy of Lincei (Rome) for ViraI Studies (Former winner S. Stewart)
• 1971 "D. De Blasi" National Award from Richardson Merrel
• 1973 "Gold Microscope" International Award from Italian Health Minister (Former winners.A. B. Sabin, S. Luria)
• 1973,1975 G. D'Orso National Award (Naples) (AIso winner R. Dulbecco)
• 1975 "Gold Jumbo Jet" International Award at Capitolium Rome (Former winner D. Bovet)
• 1975 Gold medal from the President of Italian Republic for achievements in public education
• 1976 Knights of Humanity International Award, Malta
• 1978 International Universum Award for Medicine from the International Center of Solidarity "Giovanni XXIII" (Former winner C. Barnard)
• 1978 Gold medal and honorary member, International Academy of Pontzen
• 1979 Gold medal and director for MedicaI Science, Academy of Paestum
• 1979 Diploma and academician title from the RomanAcademy of medical and biological Sciences, Capitolium (Rome)
• 1979 Gold Lion National Award from the Lion Brigade, Pistoia (Former winner: famous Italians in Art, Culture and Sciences)
• 1979 Special honour and title (Commendatore of Grace,,) from Sovereign Order of Saint John of Jerusalem, Malta (Knights of Malta,)
• 1979 Special honour and title (Comm. of Masterly Grace) from Order of S. Brigitte of Svevia
• 1981, 1986 Tifeo Award for science and Medicine from International Center of Culture, Rome-lschia
• 1982 National Award for Sciences, under the patronage of Health Minister, at Capitolium, Rome
• 1983 Special honour and title ("Great Official of Masterly Grace,,) from Sovereign Order of S. George in Carinthia (Karrnten)
• 1983 Star of Europe Award for European Cavalier Union, Rome
• 1983 International Prize "Riace Warriors" from the Templari, Culture Society
• 1983 National Award of the South "Gold Marmaid" of Palinuro for medical studies, under the patronage of the President of the ItalianRepublic
• 1985 National Award for the Culture from the Presidenza del Consiglio dei Ministri
• 1987 First Prize in Biomed. Research, ItalianAcademy of Arts and Sciences
• 1989 Laurea Honoris Causa in MedicineCatholicUniversity, Albany, New York
• 1990 Member of Academic Senate of Costantinian University, Providence, Rhode lsland, USA
• 1991 Laurea Honoris Causa in Immunology, St. Theodora Academy, New York
• 1991 Castello di Pietrarossa Award, Caltanisetta (also Winner H.H. Fudenberg)
• 1991 Decorated Comdr. ltalian National Order of Merit
• 1992 International Award "Cesare d'oro", Padova
• 1994 Member of Academy Senate Pro Deo University, New York
• 1994 Kinght Grand Cross Sovereign Constantinian Order St. George
• 1994 Gold Little Horse, Transnational. European Federation, Rome
• 1995 Laurea Honoris Causa in Bioethics, ConstantinianUniversity, Cranston, Rhode Island
• 1996 King Manfredi award, Manfredonia
• 1999 Equestris Ordinis S. Sepulcri of Jerusalem, Rome
• 1999 Gold medal of health PresidentItalianRepublic, Rome
• 1999 GreatOfficerItalianRepublic Order of Merit
• 1999 Saint Catherin Award, Siena
• 2001 Honorary academic Member University Sancti Cyrilli, Valletta, Malta
• 2003 Honorary Rector Ruggiero II University, Florida
• 2003 Sorrento in the World Award, Sorrento
• 2005 Medal of Minister for Culture, Viareggio
• 2006 Knight of Solidarity Internat. Award Norman Acad., Rome
• 2006 Saint Pio for Peace award City of Fiuggi.
• 2006 Tables of Law award Internat. Assn. Cath. Apostleship, Naples.
• 2007 Casentino award for medicine, Poppi, Arezzo
• 2008 Award Pres. Italian Rep., silver medal
• 2009 Lifetime Achievement award, Sbarro Health Research Orgn. Philadelphia
• 2010 Grand Prix Solidarite Dem. Rep. Congo
• 2010 National award for solidarity Fratres St. Giovanni La Punta
• 2011 Global Education Sanremo award
• 2011 International Peace Award
• 2012 AAAS member Royal House Aranan (Philippine) (Gold medal)
• 2012 International Prize Le Muse Florence
Selected publications (over 500 articles in total)
• Recherches sur le mechanisme d'action d'un groupe de medicaments a activité antivirale (produits chetoaldéhydiques du diphényle et leur derivés): Facteurs qui interferent sur leur activité protectrice in vivo. (with F. Magrassi, P. Altucci et al.). III Internat. Congr. Of Chemotherapy – Stutgart, July 1963. Proceedings, pag. 783 (1964).
• Studies on the mechanism of antiviral activity of ketoaldehyde derivates of biphenyl. (with F. Magrassi, P. Altucci et al.) International "Symposium on non specific resistance to virus infection, Interferon and viral chemotherapy" Smolenice, September 1964. Chemotherapia 9, 341, 1964.
• Studies on the mechanism of antiviral activity of biphenyl ketoaldeydes. (with F. Magrassi, p. Altucci et al.) Proceedings of the Fourth Congress of the Hungarian Association of Microbiologists Akadémiai Kiado Budapest 1964, pag. 11.
• Properties of an avirulent influenza A virus variant derived from drug treated mice infected with PR8 virus. (with F. Magrassi, et al.) In "Antimicrobial Agent and Chemotherapy" pag 605 (1965).
• Properties of an avirulent influenza A virus variant derived from drug treated mice infected with PR8 virus. (with F. Magrassi, et al.) Arch. ges. Virusforsch, 18, 422, 1966.
• Effect of Streptovitacin A on replication of RNA virus (poliovirus). Proc. Soc. Exp. Biol. Med. 126, 535. 1967.
• Virus Specific, Labile, Nonvirion Antigen in Herpes Virus Infected Cells. (with A. B. Sabin) Proc. Natl. Acad. Sci. U.S. 65, 753, 1970.
• Increase in Preexisting Cellular Antigen Combining Groups al Different Times after Infection with Different Viruses. (with A. Sabin) Proc. Natl. Acad. Sci. U.S. 67, 731, 1970.
• Studies on the mechanism of antiviral activity of Ketoaldheide derivates of bifhenil. (with F. Magrassi et al.) Rev. roum. d'inframicobiol. 5, 275, 1968.
• Effect of two methisazone derivatives on herpes simplex virus replication. (with P. Mastroeni). VII Intern. Congress of Chemoterapy, August 1971 Avicenum, Czechoslovak Medical Press, Praga, pag. 273.
• Soluble Membrane Antigens of Lip and Cervical carcinomas: Reactivity with Antibody for Herpesvirus Nonvirion Antigens. (with A.C. Hollinshead) Science 179, 698, 1973.
• Apperance in Trypsinized Normal Cells of Reactivity with Antibody Presumably Specific for Malignant Cells. Proc. Nat Acad. Sci. USA 70, 325, 1973.
• Nonvirion Antigens Produced by Herpes Simplex Viruses I and 2. (with A. B. Sabin) Proc. Nat. Acad. Sci. USA, 70, 1032, 1973.
• Herpes Simplex and Herpes Genitalis Virus in Etiology of Some Human Cancers. (with A. B. Sabin) Proc. Nat. Acad. Sci. USA, A70, 3225, 1973.
• Studies of Tumor-specific and Herpes Virus Non virion Antigens. (with A. Hollinshead et al.) Cancer Res. 34, 1122, 1974.
• Characterization of herpesvirus non virion antigens: relation to squamous cell carcinomas.(with A. Hollinshead, W. Rawls e P. Chretien) In E. Kurstak and R. Morriset (ed) "Viral Immunodiagnosis", Academic Press, New York, 1974.
• Soluble Membrane Antigens of Lip and Cervical carcinomas: Reactivity with Antibody for Herpesvirus Nonvirion Antigens. (with A.C. Hollinshead) Year Book of Cancer 1974.
• Analysis and Description of Procedures Used in the Study of the Relationship of Herpes Simplex "Nonvirion" Antigens to Certain Cancers. In C. de Thé, M. A. Epstein, H. zur Hansen (ed.) "Oncogenesis and Herpesviruses" I.A.R.C., Lyon 1975.
• Preliminary studies of nonvirion antigens associated with Herpes Simplex virus 1 and 2 (HSV-1- HSV-2) (with Accini R. et al.) Boll. Ist. Sieroter. Milanese 55, 120 1976
• Herpes Simplex virus nuclear non virion antigens detected by anticomplement immunofluorescence (with Giordano C. et al.) Tumori 62 (6) 609, 1976
• Herpes Simplex virus tumour associated antigens in cancer patients (with Di Gioia M. et al.) Tumori 62 (6) 615, 1976
• Cell-mediated immunity to Herpes Simplex virus types 1 and 2 antigens in leucoplakia and carcinoma in man. (with E. J. Shillitoe, T. Lehner) Oncology 33, 192, 1976.
• Detection of early antigens in nuclei of cells infected by cytomegalovirus, Herpes Simplex type 1 and 2 by anticomplement immunofluorescence and blocking assay to demonstrate their specifity.(with G. Giraldo, E. Beth, U. Hammerling, F.M. Kourilsky)Int. J. Cancer 19, 17, 1977.
• Enzyme Linked Immunosorbent Assay for Herpes Simplex Virus Tumor-associated Antigen. (with R. Cocchiara et al.) Cancer 45, 938, 1980.
• An Immune Enzymatic Assay for Purified Tumor Associated antigen of Herpes Simplex Virus.(in coll.) Cellular and Molecular Biology 25, 329, 1980.
• Purification of Herpes Virus Tumor Associated Antigen from Human Kidney Carcinoma. (with R. Cocchiara et al.) Cancer 46, 1594, 1980.
• Foreword of the proceedings of the First International Congress of Viral Oncology The role of Virus in Human Cancer, vol. 1 Elsevier, North Holland, 1980.
• Herpes Simplex Virus Tumor Associated Antigen (HSV-TAA) Detected by the Enzyme-Linked Immunosorbent Assay (ELISA). in The Role of Viruses in Human Cancer, vol. 1, Giraldo e Beth Editori, Elsevier North Holland inc., pag. 108, 1980.
• Il TAF test: un nuovo metodo per la diagnosi di alcuni tumori. Rivista Medica della Svizzera Italiana 45, 245, 1980
• Monoclonal Antibodies to Herpes Simplex Virus Tumor Associated Antigen. (with A. Karpas e T. Wheeler) International Workshop on Herpesviruses Soc. Edizioni Esculapio, Bologna 1981, pag. 232.
• Circulating Immunocomplexes (CIC) in Sera of Patients with Herpes Simplex Virus (HSV) - Associated carcinomas. (in coll.) International Workshop on Herpesviruses Soc. Edizioni Esculapio, Bologna 1981, pag. 236.
• Traitment de la herpetique avec le metiseprinol. Aspect clinique et histologique (with Gorgone G., Cavallaro N., Scaletta S., Carnazza S., Ricci M., Gala Trinchera G., Cordaro S.) Bull. Soc. Belge Ophtal. 192 113-123 1981
• Perspectives and limits of an immunoenzymatic assay (ELISA) for Herpes Simplex Virus (HSV) Tumor-Associated Antigen (TAA). Cancer Detection and Prevenction 4, 47, 1981.
• An immunoenzymatic assay for herpes simplex virus tumour associated antigen in gynaecological oncology (with Magli G., Scimone C., Flaminio G., D’Alessandro G., Mascolo A., Magli R., Saladino I.) Eur. J. Gynaec. Oncol. 1982 ISSN: 0392.2936.III.2
• Further Studies on an Immunoenzymatic Assay for Heres Simplex Virus-Tumor Associated Antigen. (in coll.) Clin. Immunol. Immunopath.. 25, 126, 1982.
• Human tumor antigens inducing in vivo delayed hypersensitivity and in vitro mitogenic activity. (with A. Pederzini et al.) Oncology 40, 248, 1983.
• As above Immunomodulation amd Therapy in Cancer (with Pedercini A. et al.) ed. H.H. Fuderberg, P. Pontiggia, C. Ogler, Acta Medica edit. Congressi 1983, pag. 307
• Virological Investigation of Young Children with Acute Respiratory Syndrome Associated with Respiratory Synctyal Virus (RSV). (in coll.) in Medical Virology II, Editor L.M. de La Maza, E.M.. Peterson Elseiver Biomedical, 1983, p. 402.
• Quantitative Determination of Human CMV IgG Antibodies by solid phase enzyme immunoassay: comparison with CF test. (in coll.) in Medical Virology II - Editor L.M. de La Maza, E.M.. Peterson Elseiver Biomedical, 1983, p.392.
• Correlation between immune complexes and Herpes Simplex Virus (HSV) Tumor Associated Antigen (TAA) in Human Cancer Sera. (with others) Cellular and molecular biology 29, 394, 1983.
• The role of herpes simplex virus in the neoplastic pathologies and diagnostic markers. J. Exp. Clin. Cancer Res. 4 (2),213, 1985.
• Serological and Virological Investigations of Young Children with Acute respiratory Syndrome Associated with Respiratory Syncytial Virus. Diagnostic Microbiology and Infection Disease 3 (1), 81, 1985.
• The pathogenesis of malignant tumors X Dies Italico-Iugoslavici Medicinae destinati, Lugnano, 1985
• Screening haemodialysis patients for infection with human immune deficiency virus (HIV). Journal of Infection 14, 1987, pag. 229.
• Absence of risk of human immunodeficiency virus (HIV) infection in recipients of hepatitis B vaccine. Eur. J. Epidem. 3, 1987, pag. 323.
• Viruses and immunodeficiences. "Regulation of Mammalian Cell Growth", Capri 27-9/2-10-87, pag. VIR 9, Ciba-Geigy.
• Monoclonal antibody for tumor associated antigens induced by Herpes Simplex Virus. Advances in Management of Malignancies, Proceedings of an international congress, Ascoli Piceno, 3/6-5-1988.
• Laboratory methods for diagnosis of AIDS. Significance of sierological markers (with others) Giornale italiano di patologia clinica 3 (6) 1988, pag. 393
• Search for tumour antigens to be used for active specific immunotherapy. Abstract book of the 2nd Internationl Congress “Advance in Management of Malignannces, Ascoli Piceno 28/5-1/6/1990 pag. 36
• Histochemistry and Immunolohistochemistry in the diagnosis of prostatic carcinoma (with others) Abstract book of the 2nd International Congress "Advances in Management of Malignancies", Ascoli Pisceno, 28/5-1/6-1990, pag. 93
• Epidemiological, serological, evolution aspects of HIV infection and related malignancies within Naples area (Jan '86-Dec. '89). Abstract book of the 2nd International Congress "Advances in Management of Malignancies", Ascoli Pisceno, 28/5-1/6-1990, pag. 19.
• Methoden in vitro als tierversuchersatz bei immunologishen studien. in AA.VV. "Artze fur Die Abschaffung der Tierversuche" Bern 1990, p. 77 (German); p. 167 (French); p. 255 (Italian).
• Neutralization test and antibody titers in AIDS (with Valguarmera G. et al.) Clinica Europea 30 (2) June 1991
• HIV Infection and Serological Response (with Esposito C. et al.) Biochimica clinica 15, 1991
• Seroepidemiologic patten of HCV infection in Campania during the first six months 1992. (with C. Esposito et al..) Abstract, Journal of Hepatology supplement 1 to vol, 17, 5028, 1992
• Screening of HTLV-1 infection drug addicts from Campania region. Advances in Management of Malignancies Pisa, 6/10-12, 1993, pag.33 BIOS Ed.
• Lung carcinoma histopatholocic approaches for a prognostic valuation (with others) Advances in Management of Malignancies Pisa 6/10- 12/1995 pag. 237 BIOS ed.
• Antigenic regions of tumour liberated protein complexes and antibodies against the same (with. Marshak DR et al) In Third International Congress. Advances in Management of Malignancies. Pisa, Italy 6/10 December 1993 Biomed & Pharmacother 47:237
• Vom Anthropozentrismus zur Antivisektion: Tierschtz heute und Jurassic Park. Proceedings of International Medical Congress, Lugano 20-11-93. LIMAV, pag. 195 Ed. ASTRA/AG STG March 1995.
• Passive immunotherapy in AIDS patients Rivista Italiana di Ricerche Mediche e Chirurigiche Anno III vol. 3 n. 3 September 1995 pag. 11
• Anti-TLP antibodies in lung cancer patients. (with C. Esposito et al.) Internal Medicine Clinical and Laboratory 5 191-194, 1997.
• The Genoma Project: Ethical implications in oncology. In: Internal Medicine Clinical and Laboratory 6 67-72, 1998
• Immunoistochemical characterization of tumour liberated particles (TLP) expression pattern in
lung cancer. (with Giordano A. et al.) Anticancer Res 18:2365-2370, 1998
• Los derechos de los animales Actas Congreso medico international LIMAV Madrid Mayo 1997 ARTA STG enero 1998
• Effect of Bergarital on virus replication Rivista Italiana di ricerche Mediche e Chirurgiche Editrice Doctor’s Anno VI n. 2/4 aprile/dicembre 1998
• Neoangiogenesis and prognosis in lung cencer (with A. Perna et al.) Internal Medicine Clinical and Laboratory 7 111-113, 1999
• Tumor liberated protein (TLP). Its potential for diagnosis and therapy. Anticancer Res 19: 1755-1758, 1999
• Immunità da Herpes Simplex Virus (HSV) (with others) Proceedings of International Workshop on Viruses Immunities and Diseases, Naples, October 1999
• AIMS and Perspectives for Tumor Liberated Protein (TLP) Proceding of the Joint International Cancer Conference “New Dimension in Cancer Biology on Therapy” Edition H. Ozer, K. Khalili, G.C. Giordano
• As above Riv It Ric. Med Chir 7:43-46 1999
• Vom Tumor freigesetze Proteine: Neuer Wendepunkt fur Diagnose und Therapie ohne Notwendigkeit von Tierversuchen. Humanmedizin ohne Tierversuche: Die Artze haben das wort. Berlin Mai 1999, ASTRA – AG STG pagg. 67-74
• Overview of the Lung Tumor Liberated Protein (TLP): Characterization of Genetic Immunologic Profile Internal Medicine Clinical and Laboratory 8 33-38, 2000
• Immunochemical evaluation of endothelal damage by angioinvasivity. (with Perna A, et al.) Int J. Clin Invest 9 :31-33, 2001
• Production and characterization of anti-TLP derived peptide RTNKZEASIC) monoclonal antibodies. (with Esposito C. et al.) Int Med 9:55-61, 2001
• Characterization of a Fragment Containing a Putative TLP DNA Sequence. Anticancer Research, 22: 2693-6, 2002
• UCV genotypes and antibodies reactivity what's relation? Journal of Hepathology Suppl. n.1, Vol.30, 1999 pag.209. (with C. Esposito, F. Morelli, N. Cuomo, A. Di Spirito)
• Evaluation of a new test for the determination of the genotypes HCV JournaI or Clinical Virology, 22/2: 174, 2002
• Hepatopaty and oxidative stress: clinical study on the efficacy of the depatox Int.. Clin. Invest. 1 : 15 -18, 2003
• Determination of the HBV polymerasis gene mutation in HBV ECA patients treated and naive. (with Esposito C. et al.) Journal of Clinical Virology suppl. August 12 27 2003,
• Progress and new hope in the fight against cancer: novel developments in early detection of lung cancer.(with C. Esposito), in InternaI Medicine 10 7-11, 2002
• Extracorporeal Whole Body Hyperthermia in the treatment of C Hepatitis.IJCI Int.. Clin. Invest. XII 1 – 4, 9 -10, 2004
• Stem cells. State of art and perspectives. Biomedicine and Pharmacotherapy 58 463-464, 2004
• Early diagnosis of lung cancer by detection of Tumour Liberated Protein Journal of Cellular Physiol 203 1-5, 2005
• Biomolecular Markers of breast Cancer (with A. Nicolini and A. Carpi). Frontiers in Bioscience
• (United States), 2006, 11 pag. 1818-43
• New hope in early detection of NSCL cancer
• New Research Communications on Tumor Markers
• Nova Publisher, New York, N.Y., in press
• TLP in Screening, early diagnosis and follow up of NSCLC Int. J. Clin. Invest. 3-4; 75 – 82, 2006
• Tumor Liberated Protein from Lung Concer and Perspectives for Immunotherapy Journal of Cellular Physiology, 221: 26-30, 2009.
• Consideration on Epidemic Flu Viruses. (Int. J. Clin. Invest., 29 (1-2): 2009.
• Preface to lose weight without misteries will the Progressive Swing Diet by Michele D’Antoni, iUniverse, Inc. New York bloomingtore, 2009. Not any longer sick children: prevention of viral diseases in pregnancy. WABT Congress, Budapest Dec 10-12, 2010 – Book for Life Foundation.
• Giulio Tarro U.S. National Library of Medicine - National Institute of Health – National Center for Biotechnology Information, Pub Med EN/IT. Chiron, Settembre 2010.
• Emerging Viral Agent at Risk in Global Health Approciates to Early Diagnosis and Prompt Therapy, con C. Esposito. BIOCOMP 11: July 18-21, 2011, Las Vegas, Nevada (USA) CS REA Press.
• Lung Cancer Proteomics: Recent Advances in Biomarkers Discovery, con P. Indovina, E. Marcelli, P. Maranta. International Journal of Proteomics Vol. 2011 Article ID 726869, 7 pages.
• Mass – spectrometry based proteomic the road to lung cancer biomarker discovering Predictive, Preventive and Personalized Medicine (PPPM) con P. Indovina, E. Marcelli, F. Pentimalli, P. Tanganello ed A. Giordano. Mass – spectrometry Reviews, Springer SMA Journal: PPPM in Cancer 2012.
• VirusSphere, Doctor Mag, The Medical Web Magazine.
• Peptide Search in the Tumor Liberated Protein (TLP) from Non Small Cell Lung (NSCL) Cancer.
BIT’s 4th Annual World Congress of BioSoft, March 23-25, 2012, Beijing China.
• Search in the Tumor Liberated Protein (TLP) for Specific Peptides of Non Small Cell Lung (NSCL) Cancer. BIOCOMP 12: July 16-19, 2012, Las Vegas, Nevada (USA) CS REA Press.
• Tracking the 2009 H1N1 Influenza Virus in the Italian Region Campania, con C. Esposito, A. Di Spirito et al. Journal of Cellular Physiology Vol 227: 2813-2817, July 2012.
• TLP Sequenced and Studied for its Functions with Targets Diagnostic and Therapeutic, G. Tarro. Advanced Studies in Biology, Vol 5, n. 5, 191-198, 2013 HIKARI Ltd.
• From Sequence of Tumor Liberated Protein (TLP) to Function and Potential Targets for Diagnosis and Therapy, G. Tarro. BIOCOMP 11: July 2013, Las Vegas, Nevada (USA) CS REA Press
• Origin of the Viruses and their Evolutionary History, G. Tarro. Advanced Studies in Biology, Vol 5, n. 9, 423-430, 2013 HIKARI Ltd.
• New Development on Tumor associated Antigen with specific target toward Lung Cancer, G. Tarro. International Journal of Research in Medical and Health Sciences, Vol. 4, Issue 2, ISSN 2307-2083, 29 June 2014.
• Viral Latency, Molecular Pathogenesis and Malignancy, G. Tarro. Global Journal of Science Frontier Research © Vol. XIV, Issue III, Vers. I, 2014.
• L’epidemia da virus Ebola. www.assis.it , 27 agosto 2014.
• Micoplasmi e micoplasmosi: 20 anni dopo, G. Tarro, P. Altucci. Estratto da Il Policlinico – sez. Pratica, vol. 121 – N. 9, Settembre 2014, pagg. 229-245.
• Ruolo dell’Etio-patogenesi in Medicina Interna. P. Altucci e G. Tarro. Policlinico Sez. Med. 2014; 121: 61-81, doi. 107353/polimed.2014.121.
• Migratory Phenomenons, Biothics and Vaccinations Advances in Microbiology (accepted Sept 2015) in cod 8 I. F. = 0,94.
• Bergamot (Citrus bergamia Risso and Poitean) Essential Oil,. Peel and Juice: a Review of Antimicrobiol, Anti-inflemmatory and other Medicinal Properties with Paolo Morabito et al. Clin. Microb. Rev. (accepted Sept 2015) in c.d.p. I.F. = 17.
• Lights and shadows of vaccinations. J of Vaccine Research and Development in c.d.p.
• Exegesis of Sabin poliovaccine in terms of medical science. J of Vaccine Research and Development in press.
• Le ombre dell’immunoprofilassi. Bollettino Ordine M.C. e O. Napoli, anno 85 n. 7 pagg. 12-13, dicembre 2015.
• Anti-Rhinovirus Activity of Ethyl1 4-(3-(2-(3-Methylisoxazol-5-Y1) Etthoxy) Propoxy) Benzoate (EMEB). Pharma Anal Acta 2016, 7:469. Doi: 10.4172/2153-2435.1000469.

• Oncologic Virology, Idelson, Naples 1979
• Pathology of AIDS, Mapograf, Vibo Valentia 1991
• With cancer one can live, Mapograf, Vibo Valentia 1992
• AIDS: what we can do what we must know, Mapograf, Vibo Valentia 1994
• Pocket File Research Collection, Doctor’s, Naples 1997, 6th edit., 2003
• To Prevent Is To Win, Italia Sud, Rome 1998
• Bioethics and Culture of Prevention, Apẻiron, Bologna 2001
• Health without borders, Imago Media, Edition Piedimonte Matese, December 2004
• Health without borders, number 2, Rubbettino Editore, Soveria Mannelli 2007
• Safety no limits, Cassa Risparmio San Miniato 2008
• Health without borders, 4. Ed. Helicon Arezzo 2009.
• Medicina e Recenti Miracoli, Totus tuus edit. 2010.
• Sanità senza frontiere 5, ed. Chiron, 2012.
• Campania, terra di veleni, Denaro libri, 2012.
• La medicina è la Vita. Essere medico nell’era della Globalizzazione
Ilmiolibro.it, editoriale l’Espresso. Libri per Amici. ISBN: 978-88-91050-73-1 Copyright 2013
• La medicina è la Vita. Essere medico nell’era della Globalizzazione
Ilmiolibro.it, editoriale l’Espresso. Libri per Amici. ISBN: 978-88-91063-38-0, anno 2013
• Il cancro dovrebbe essere solo un segno zodiacale. Tutti insieme contro il cancro!
Edito dalla Fondazione de Beaumont Bonelli per le ricerche sul cancro – ONLUS. 31 Ottobre 2013
• Il cancro dovrebbe essere solo un segno zodiacale. Tutti insieme contro il cancro!
Edito dalla Fondazione de Beaumont Bonelli per le ricerche sul cancro – ONLUS. Marzo 2015
• Sanità senza frontiere n 6
• Curriculum vitae et studiorum

Mirta D’Ambra, MD

University Professor of Medicine Head of epidemiological surveillance Ministry of Health
Doctor of Medicine University Buenos Aires (1980)
World Academy of Medical Sciences
Chairman of "WAMS Argentinian Council" (2017)
Specialist in Pediatrics (U.B.A) 1984
Specialist in Neonatology (U.B.A.) 1989
Specialist in all branches of Public Health (2005)
Epidemiology (U.B.A)
Specialist in diseases transmissible by viruses, bacteria, parasitism, mosquitoes

Work history
Associate Membership of the World Society for Virology(2018)
Head of epidemiological surveillance Ministry of Health (Current)
Chief Aréa Programmatic (2016)
Society member of neonatal fetus diseases
University Professor of Medicine (chief of practical work) Current
Auditor of diseases low incidence and high danger (Ministry of Health Province of Buenos Aires) 2015
Speaker at National and International conferences
Works Published in national and international journals……etc

Dr. Ian James Martins

Edith Cowan University Australia
Dr. Ian James Martins is an Editor/Reviewer for Open Acess Pub/MDPI journals and various other international journals. Advisory Board Member for Photon Journal. Fellow of International Agency for Standards and Ratings (IASR). Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. Chief Editor for International Journal of Diabetes Research (2014-2018), Research and Reviews: Neuroscience (2016-2018) and Journal of Diabetes and Clinical Studies (2017-2018). BIT Member (BIT Congress. Inc) with an H-index of 64, (ResearchGate STATs (27), Scopus Author ID: 7103152779/Mendeley STATS (21), UWA Research Repository (16). Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu. The citations past 27 years have accumulated to >4584. Ian James Martins - Semantic Scholar https://www.semanticscholar.org/author/Ian-James-Martins/5258067. Semantic Scholar profile for Ian James Martins, with fewer than 50 highly influential citations RESEARCHGATE ANALYSIS: Ian J Martins | Ph.D. | Centre of Excellence for Alzheimer's Disease ...https://www.researchgate.net/profile/Ian_Martins2 under Ian James Martins’ name places publication RG score (> 96%) of international SCIENTISTS. ORCID CONNECTING RESEARCHER: Editorial Team www.macrothink.org/journal/index.php/jfs/about/editorialTeamBio/13511 Editorial Team. Ian James Martins. Ian James Martins Mail · http://orcid.org/0000-0002-2390-1501. Edith Cowan University, Australia. Prestigious Recognition of Lifetime Membership by the International Agency for Standards and Ratings as Fellow for Diabetes, Medical Science (Nutrition). Winner (World Academic Championship -2017) in Diabetes and Medical Science (Nutrition). Certificates from various international conferences have been received in relation to anti-aging, health, and disease. Keynote addresses at, Biomedicine 2018 (Osaka, Japan), Global Experts Meeting on Diabetes, Hypertension, Metabolic Syndrome 2018 (Melbourne, Australia), Immunology World 2018 (Amsterdam, Netherlands), Laboratory Medicine 2018 (Berlin, Germany), Innovate Pharma 2017 (Sydney, Australia), Innovate Neurology 2017(Sydney, Australia) World Diabetes and Endocrinology Summit-2017 (Dubai), Pharmacology and Ethnopharmacology 2016 (Chicago, USA) and AGHC 2016 (1st Plenary Speaker, Kaohsiung, Taiwan). Chair/Co-chair Sessions on Laboratory management, Cytogenetics, Clinical Microbiology, Diagnostic Laboratory Medicine etc, 13th International Conference on Laboratory Medicine and Pathology, Berlin, Germany, June 25-26, 2018, Chairing Sessions on Vaccinology, Immunopathology, Immunotherapy, Immune Proteomics, Cancer and Tumour Oncology, 7th World Congress on Immunology, Amsterdam, Netherlands, April 19-20, 2018, Chair, Pipeline 1: Biotherapeutics for Diseases, Bit's 2nd International Congress of Biotherapy-2018 (Programme Committee Member), Chair, Innovate Conferences 2017, Chair/Co-Chair at congress World Gene Convention-2016 (Shanghai, China, Pharmacology and Ethnopharmacology 2016 (Chicago, USA), Annual World Congress of Diabetes-2014 (Haikou, China), World Gene Convention-2014 (Haikou, China). Research Activity Statistics have been provided by Publons with a comparison to other researchers. Ian James Martins is now in the 98th percentile as assessed for Publons users by merit. Dr. Ian Martins is a reviewer for approx. 47 journals over the past 5 years.
Anti-Aging Genes, Global Health and Chronic Disease, Food and Nutrition, Appetite, Environment, Senescence.
Research Grants Awarded
Chief/Associate Investigators:
NHMRC 595312 & NHMRC 595300 Prof. R.Martins, Dr. I. Martins, D K.Taddei, Dr. M. Ladu, Dr. M. Sharman 2010-2012 $938,775
The effect of human apo E isoforms and apo E receptors on the clearance of oligomeric abeta42 by hepatocytes in vitro Enhancing peripheral clearance of beta-amyloid as a treatment for AD
Prof. R.Martins, Dr. I. Martins, Dr. G Verdile, Dr. J.Phillips. 2007-2009 Continuing. Alzheimer’s Disease and Research Care 327,890
Investigating beta-amyloid clearance in vivo
Chief Investigator:
NHMRC 324100 Prof. R.Martins, Dr. I. Martins, A/Prof Nicola Lautenschlager 2005-2007 $422,750
Molecular and Neuropsychological Predictive Markers of Cognitive Decline
ECU Small Grant Chief Investigator: Dr. I. Martins 2006 Current Status: Completed $5000
Cholesterol, High-fat diets, exercise, and cholesterol-lowering drugs on beta-amyloid Clearance and deposition in brains of Alzheimer’s transgenic mice Hollywood Pvt Hospital Res Grant Dr. I. Martins 2006 Current Status: Completed. $10,000
Raine Research Foundation Dr. I. Martins 1999-2000 Current Status: Completed $169,000
Metabolism of postprandial lipoproteins in mice and man Innovax Ltd. Co-Chief investigator on Industry Grant: 1994-1998 Current Status: Completed $1,200,000
Development of a breath test for chylomicron remnant metabolism in mice and man Athelstan and Saw grant Chief Investigator Dr. I Martins 1994 Current Status: Completed $50,000
Effects of butterfats and oils on the clearance of chylomicron remnants NHMRC Co-investigator: Dr. I Martins 1993-1995 Current Status: Completed $150,000
Binding and endocytosis of chylomicron remnants by low-density lipoprotein receptors and proteoglycans to liver cells
1. Martins IJ. Insulin Therapy and Autoimmune Disease with Relevance to Nonalcoholic Fatty Liver Disease. Non Alcoholic Fatty Liver Disease. An Update. IntechOpen. October, 2018. https://www.researchgate.net/publication/328190122_Insulin_Therapy_and_Autoimmune_Disease_with_Relevance_ to_Nonalcoholic_Fatty_Liver_Disease
2. Martins IJ. Anti-Aging Gene linked to Appetite Regulation Determines Longevity in Humans and Animals. International Journal of Aging Research. 2018,1(6): 1-4.
3. Martins IJ. Heat Shock Gene Inactivation and Protein Aggregation with Links to Chronic Diseases. Diseases. 2018, 6;39:1-5.
4. Martins IJ. Electroconvulsive Therapy and Heat Shock Gene Inactivation in Neurodegenerative Diseases. Ann Neurodegener Dis. 2018, 3(1): 1028.
5. Martins IJ. Genomic Medicine and Acute Cardiovascular Disease Progression in Diabetes. International Journal of Medical Studies. 2018;3(1): 124-130.
6. Martins IJ. Genomic Medicine and Management of Genetic Disorders. J Genet Disord. 2017; Vol. 1 No.1: 06.
7. Martins IJ. Single Gene Inactivation with Implications to Diabetes and Multiple Organ Dysfunction Syndrome. J Clin Epigenet. 2017, Vol. 3 No. 3:24.
8. Martins IJ. Regulation of Core Body Temperature and the Immune System Determines Species Longevity. Curr Updates Gerontol. (2017) 1: 6.1
9. Martins IJ. Heat Therapy With Relevance to the Reversal of NAFLD and Diabetes. J Diabetes Metab Disord. 2017; 4: 018.
10. Martins IJ. Heat Shock Gene Dysregulation and Inactivation of Drug Therapy. EC Pharmacology and Toxicology. ECO.01 (2017): 13-15.
11. Martins IJ. Geriatric Medicine and Heat Shock Gene Therapy in Global Populations. Curr Updates Gerontol. 2016;1: 1-5.
12. Martins IJ. Heat shock gene Sirtuin 1 regulates post-prandial lipid metabolism with relevance to nutrition and appetite regulation in diabetes. International Journal of Diabetes and Clinical Diagnosis. Int J Diab Clin Diagn. 2016, 3:20.
13. Martins IJ. Type 3 diabetes with links to NAFLD and Other Chronic Diseases in the Western World. International Journal of Diabetes. 2016; 1:1-5.

Taher Slimi, PhD

Medical Imaging Researcher Doctoral Higher Institute of Biomedical Engineering 7100, Montplaisir, Tunisia
2014 – 2017: Ph.D. in Biomedical Engineering, Medical Imaging, Medical Physics, and Biophysics
Ph.D. dissertation: Research of new breast imaging techniques in ultrasound elastography: Breast tissue displacement estimation.
University of Tunis El Manar, Doctoral Higher Institute of Biomedical Engineering.
In collaboration with the Laboratory of Medical Engineering Techniques and Complexity (TIMC-IMAG - UMR 5525), Grenoble, France.
2012 – 2014: Research Master’s degree in Biomedical Engineering, Medical Imaging, Medical Physics
University of Tunis El Manar, Doctoral Higher Institute of Biomedical Engineering.
2010 – 2012: Professional Master’s degree in Biomedical Engineering.
University of Tunis El Manar, Doctoral Higher Institute of Biomedical Engineering.
2007 – 2010: License degree in Biomedical Engineering
University of Tunis El Manar, Doctoral Higher Institute of Biomedical Engineering.
Professional and Teaching experience
Since June 2018: Medical Imaging Researcher at Doctoral Higher Institute of Biomedical Engineering. (Description: Machine learning/deep learning techniques for medical imaging diagnostic).
July 2017-May 2018: Medical Imaging Engineer at Samsung Healthcare-Axone-Medical, Tunisia.
July 2013-February 2016: Biomedical Engineer at iTMed (Informatics and medical technologies).
Since September 2013: Contractual Professor Assistant (Course title: Medical imaging, Medical physics, Image post-processing, Matlab, C++, Medical and nuclear instrumentation, biophysics). University of Tunis El Manar, Doctoral Higher Institute of Biomedical Engineering.
Journal papers
[1] Slimi Taher et al., Improvement of displacement estimation of breast tissue in ultrasound elastography using the monogenic signal. BioMedical Engineering OnLine. 2017;16:19.
[2] Slimi Taher et al., Improvement of Breast Elastogram Quality in Static Ultrasound Elastography using Biophysical Parameters. J Diagn Tech Biomed Anal. 2017; 6:1.
[3] Slimi Taher et al., Optimization of Breast Displacements Estimation in Ultrasound Elastography. J Diagn Tech Biomed Anal. 2017; 6:1.
[4] Slimi Taher et al., Estimation of Displacement Tissues in Breast Ultrasound Ultrasound Elastography. J Diagn Tech Biomed Anal. 2017; 6:1.
[5] Slimi Taher et al., New Technique for Processing Tissue Displacements Estimation in Breast Ultrasound Elastography. Journal of Tissue Science & Engineering. 2018, 9:1.

Submit Manuscript

Join as a Editor